Glaxo Adds Heart Attack Warning To Avandia

Law360, New York (November 15, 2007, 12:00 AM EST) -- GlaxoSmithKline has added a “black box” to the diabetes medication Avandia warning about possible heart problems, acknowledging that the U.S. Food and Drug Administration's studies could not exclude the risks the drug poses.

The FDA announced Wednesday that Avandia's label would now warn patients that the medication could increase the patients' risk of suffer a heart attack.

“FDA has moved expeditiously to review the cardiovascular risks of this drug so that we could inform patients and doctors at the earliest possible time of our findings,” said...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.